The Scientist II, Advanced Research works within a small early research team developing next generation technologies for the detection of minimal residual disease (MRD) in cancer patients using circulating tumor DNA. The primary objective of this role is to advance a novel MRD detection method from early research through optimization to a clear assessment of technical viability.
This is a hands-on laboratory role. It requires strong practical next generation sequencing skills with an emphasis on novel library preparation methods, rigorous experimental design, and the ability to work closely with computational team members, translating method requirements into analytical specifications and jointly troubleshooting discrepancies between wet lab and computational results.
|
Responsibilities: |
Core Responsibilities:
Additional Responsibilities (may be assigned):
|
|
Position Objectives:
|
|
|
Education: |
Ph.D. in Genetics, Genomics, Molecular Biology, Biochemistry or a related field, ideally with a focus on cancer or sequencing methodology Equivalent experience will be considered: M.S. with 10 or more years, or B.S. with 14 or more years of relevant laboratory experience |
|
Experience: |
2 or more years of postdoctoral or industry laboratory experience beyond Ph.D., in a relevant field |
|
Qualification Requirements: |
|
Please contact the One Nucleus team to be put in touch with the hiring manager at NeoGenomics.
[email protected]